Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp BCTXW


Primary Symbol: T.BCT Alternate Symbol(s):  BCTX

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

Recent & Breaking News (TSX:BCT)

BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel

Accesswire June 13, 2018

Dr. Williams, BriaCell Therapeutics Corp.’s President & CEO, Discusses Recent News and Progress in an Exclusive New Audio Interview with SmallCapVoice.com

GlobeNewswire June 13, 2018

BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting

GlobeNewswire May 29, 2018

BriaCell Provides Highlights of Scientific and Clinical Findings at AACR

GlobeNewswire April 18, 2018

Dr. Williams, BriaCell Therapeutics Corp.’s President & CEO, is Featured in an Exclusive New Audio Interview with SmallCapVoice.com

GlobeNewswire April 11, 2018

BriaCell to Present Encouraging Clinical Data at AACR 2018

GlobeNewswire April 10, 2018

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

GlobeNewswire April 3, 2018

BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds

GlobeNewswire March 27, 2018

BriaCell Appoints Top Social Media Marketing Analyst

GlobeNewswire March 14, 2018

OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

PR Newswire March 8, 2018

BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million

GlobeNewswire March 7, 2018

BriaCell To Present at Precision Breast Cancer Conference

GlobeNewswire March 1, 2018

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

GlobeNewswire February 7, 2018

BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

GlobeNewswire February 6, 2018

BriaCell Presenting at Upcoming Cancer Conference

GlobeNewswire February 5, 2018

BriaCell Update:  Early Evidence of Efficacy and Safety of Bria-IMT™

GlobeNewswire January 31, 2018

BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer

GlobeNewswire January 3, 2018

BriaCell To Attend Biotech Showcase™ 2018

GlobeNewswire January 2, 2018

Dr. Bill Williams Guest Appearance at “CEO MONEY” Radio Show

GlobeNewswire December 5, 2017

BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance

GlobeNewswire November 13, 2017